Stryker Corp

Research Stryker Corp (SYK) on Bullrun: valuation model: 15.8% overvalued, market cap USD 126.72B, P/E 38.3, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSYK
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Valuation signal15.8% overvalued
• Market capUSD 126.72B
• P/E38.3
• Dividend yield1.0%
• Financial periodFY2025
• RevenueUSD 25.12B
• Revenue growth11.2%
• Net incomeUSD 3.25B
• Free cash flowUSD 4.28B
• Gross margin64.0%

Valuation Snapshot

Bullrun's latest valuation model marks Stryker Corp as 15.8% overvalued; latest market cap is USD 126.72B; P/E is 38.3; dividend yield is 1.0%.

About Stryker Corp

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.

Frequently asked questions

Is Stryker Corp overvalued or undervalued?

Bullrun's valuation model currently marks Stryker Corp as 15.8% overvalued.

What is Stryker Corp's market cap?

Stryker Corp's market capitalization is USD 126.72B.

What is Stryker Corp's P/E ratio?

Stryker Corp's price-to-earnings (P/E) ratio is 38.3.

Does Stryker Corp pay a dividend?

Stryker Corp has a dividend yield of 1.0%.

What does Stryker Corp do?

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.